4.39 USD
▼-0.21-4.57%
盘后 5.03 0.00%
2026-09-16
市值
$41.85M
市盈率
—
EPS
-2.41
股息率
—
52 周区间
4.31 – 29.98
成交量
50.52K
Beta
0.21
目标价
17.00
52W 低 4.3152W 高 29.98
价格走势
公司简介
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI...